Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
When Is the Best Time to Take Glutathione and Vitamin C
Eight healthy men were given 1 gram per day of oral glutathione or a placebo for two weeks, followed by 60 minutes of cycling at 40% maximal heart rate
One topic that's been generating some serious excitement in the world of regenerative science and our office is BPC-157
Vendors that ship from within the USA can shorten transit time and improve temperature control for research materials